NDC 0615-6567
Venlafaxine 75 mg tablet
On the label: NCS HealthCare of KY, Inc dba Vangard Labs. It's repackaged: NCS HealthCare of KY, Inc dba Vangard Labs rebottles it from Zydus Pharmaceuticals (USA) Inc.'s NDC 68382-021.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Ahmedabad, India | Makes it and tests it | Problems found, fixed voluntarilyAug 5, 2022 · 10 inspections, 3 with FDA action |
Repackaging site
- NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY, United States · repackages it
Recalls
- Mar 21, 2025 · Class II · Zydus Pharmaceuticals (USA) Inc
Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Lots: Lot #: M314265, Exp.: 31 October 2025. - Mar 5, 2013 · Class II · Zydus Pharmaceuticals USA Inc
Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.
Lots: Lot #: MM8490, Exp 09/14
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Venlafaxine: every company that makes it
- Form
- tablet, oral
- Strength
- 75 mg
- Approval
- ANDA ANDA077653
- On the market since
- Jun 13, 2008
- Package NDCs
0615-6567-39- Official label
- DailyMed (National Library of Medicine), updated Oct 27, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?